Since linc‐ROR could function as a ceRNA sponge for miR‐194‐3p and downregulate its expression, we speculate that, through the linc‐ROR/miR‐194‐3p/MECP2 regulatory axis, linc‐ROR could downregulate mTOR levels to decrease angiogenesis and then decrease the sensitivity of breast cancer cells to rapamycin. This evidence concerns the gene MECP2 and breast cancer.